---
category: news
title: "Sensome Receives FDA “Breakthrough Device Designation” for its AI-powered Stroke Guidewire"
excerpt: "Sensome, the company pioneering the connected medical device revolution with the world’s smallest biological tissue sensor, announced today that it has been granted a Breakthrough Device designation by the Center of Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for its Clotild ® Smart Guidewire System designed to improve the treatment of ischemic stroke patients."
publishedDateTime: 2021-06-21T06:00:00Z
originalUrl: "https://www.businesswire.com/news/home/20210620005074/en/Sensome-Receives-FDA-“Breakthrough-Device-Designation”-for-its-AI-powered-Stroke-Guidewire"
webUrl: "https://www.businesswire.com/news/home/20210620005074/en/Sensome-Receives-FDA-“Breakthrough-Device-Designation”-for-its-AI-powered-Stroke-Guidewire"
type: article
quality: 7
heat: -1
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI

related:
  - title: "FDA Gives PulmoSIM’s PT001 Orphan Drug Designation for PAH"
    excerpt: "The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to PT001, an investigational treatment for pulmonary arterial hypertension (PAH). The FDA gives this designation to therapies with the potential to treat rare disorders,"
    publishedDateTime: 2021-06-21T12:48:00Z
    webUrl: "https://pulmonaryhypertensionnews.com/2021/06/21/fda-gives-pulmosims-pt001-orphan-drug-designation-for-pah/"
    type: article
    provider:
      name: Pulmonaryhypertensionnews.com
      domain: pulmonaryhypertensionnews.com
    quality: 24
    images:
      - url: "https://pulmonaryhypertensionnews.com/wp-content/uploads/2020/11/shutterstock_418713622_zpsry953y6x.jpg"
        width: 1000
        height: 662
        isCached: true

secured: "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;ftcn50o21Qvzixo3Q++EmQ=="
---

